TEXT
====

Gram-negative organisms (GNOs) are the predominant bacterial pathogens at many cancer centers, and many have developed resistance to commonly used antimicrobial agents ([@B1][@B2][@B4]). Cefiderocol (CFDC) is a new siderophore cephalosporin that has been reported to be more stable than other β-lactams against β-lactamases, including NDM-1 and KPC-3 carbapenemases ([@B5]--[@B6]). Its *in vitro* activity has been evaluated against GNOs from various sources, but data against organisms from cancer patients are rare ([@B7]). We evaluated its activity against GNOs isolated exclusively from cancer patients. All organisms tested were clinical isolates (2014 to 2017), with \>90% from blood cultures. MICs were determined using a broth microdilution method ([@B8]). When available, CLSI or FDA breakpoints for susceptibility and resistance were used. Ten comparator agents were tested ([Table 1](#T1){ref-type="table"}). Trimethoprim-sulfamethoxazole was tested instead of aztreonam against Stenotrophomonas maltophilia only. Whole-genome sequencing was done on the 12 isolates that were nonsusceptible to CFDC (1 each, Escherichia coli, Pseudomonas aeruginosa, and *Citrobacter* spp.; 2 Klebsiella pneumoniae; 3 Acinetobacter spp.; and 4 *Enterobacter* spp.) ([@B9]).

###### 

*In vitro* activity of cefiderocol and comparator agents against select clinical isolates

  Isolate, type                                                    Antimicrobial agent   MIC (mg/liter)        Susceptible (%)   
  ---------------------------------------------------------------- --------------------- --------------------- ----------------- -----
  ESBL positive                                                                                                                  
   E. coli (*n* = 52)                                              Cefiderocol           2                     \<0.03 to 4       100
  Ceftolozane-tazobactam                                           32                    0.125 to \>64         82                
  Meropenem                                                        0.06                  \<0.03 to 0.25        100               
  Ceftazidime                                                      \>64                  1 to \>64             15                
  Ceftazidime-avibactam                                            1                     \<0.03 to 4           100               
  Colistin                                                         1                     1 to 4                NA                
  Aztreonam                                                        \>32                  \<0.5 to \>32         10                
  Amikacin                                                         16                    \<4 to 32             98                
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         8                 
  Cefepime                                                         \>16                  \<0.5 to \>16         10                
  Tigecycline                                                      0.5                   \<0.25 to 2           100               
   K. pneumoniae (*n* = 37)                                        Cefiderocol           2                     0.125 to \>64     97
  Ceftolozane-tazobactam                                           32                    0.25 to \>64          62                
  Meropenem                                                        0.125                 \<0.03 to 4           97                
  Ceftazidime                                                      \>64                  4 to \>64             0                 
  Ceftazidime-avibactam                                            0.5                   \<0.03 to \>64        97                
  Colistin                                                         \>8                   1 to \>8              NA                
  Aztreonam                                                        \>32                  8 to \>32             0                 
  Amikacin                                                         16                    \<4 to \>64           92                
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         11                
  Cefepime                                                         \>16                  1 to \>16             11                
  Tigecycline                                                      \>4                   \<0.25 to \>4         54                
  CRE (*n* = 40: 10 E. coli, 7 E. cloacae, and 23 K. pneumoniae)   Cefiderocol           4                     0.06 to \>64      95
  Ceftolozane-tazobactam                                           \>64                  0.5 to \>64           18                
  Meropenem                                                        \>64                  \<0.03 to \>64        18                
  Ceftazidime                                                      \>64                  16 to \>64            0                 
  Ceftazidime-avibactam                                            \>64                  0.06 to \>64          78                
  Colistin                                                         \>8                   \<0.5 to \>8          NA                
  Aztreonam                                                        \>32                  16 to \>32            0                 
  Amikacin                                                         64                    \<4 to \>64           73                
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         15                
  Cefepime                                                         \>16                  \<0.5 to \>16         68                
  Tigecycline                                                      4                     \<0.25 to \>4         65                
  *Citrobacter* spp. (*n* = 20)                                    Cefiderocol           1                     \<0.03 to 8       95
  Ceftolozane-tazobactam                                           64                    0.06 to \>64          70                
  Meropenem                                                        0.25                  \<0.03 to 8           95                
  Ceftazidime                                                      \>64                  0.25 to \>64          60                
  Ceftazidime-avibactam                                            1                     0.06 to 8             100               
  Colistin                                                         2                     1 to \>8              NA                
  Aztreonam                                                        \>32                  \<0.5 to \>32         55                
  Amikacin                                                         \<4                   \<4                   100               
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         70                
  Cefepime                                                         16                    \<0.5 to \>16         80                
  Tigecycline                                                      2                     \<0.25 to 4           95                
  E. cloacae (*n* = 38)                                            Cefiderocol           4                     \<0.03 to \> 64   90
  Ceftolozane-tazobactam                                           \>64                  0.06 to \>64          55                
  Meropenem                                                        1                     \<0.03 to 64          90                
  Ceftazidime                                                      \>64                  0.125 to \>64         95                
  Ceftazidime-avibactam                                            4                     0.125 to 16           95                
  Colistin                                                         \>8                   1 to \> 8             NA                
  Aztreonam                                                        \>32                  \<0.5 to \>32         45                
  Amikacin                                                         8                     \<4 to 16             100               
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         63                
  Cefepime                                                         \>16                  \<0.5 to \>16         66                
  Tigecycline                                                      2                     \<0.25 to \>4         90                
  *Serratia* spp. (*n* = 20)                                       Cefiderocol           0.5                   \<0.03 to 0.5     100
  Ceftolozane-tazobactam                                           0.5                   0.25 to 1             100               
  Meropenem                                                        0.125                 \<0.03 to 0.125       100               
                                                                   Ceftazidime           0.5                   0.25 to 0.5       100
  Ceftazidime-avibactam                                            0.5                   0.06 to 0.5           100               
  Colistin                                                         \>8                   \>8                   NA                
  Aztreonam                                                        \<0.5                 \<0.5                 100               
  Amikacin                                                         8                     \<4 to 8              100               
  Ciprofloxacin                                                    \<0.25                \<0.25 to 0.5         95                
  Cefepime                                                         \<0.5                 \<0.5                 100               
  Tigecycline                                                      2                     1 to 2                100               
  Acinetobacter spp. (*n* = 20)                                    Cefiderocol           4                     \<0.03 to \>64    90
  Ceftolozane-tazobactam                                           \>64                  \<0.03 to \>64        NA                
  Meropenem                                                        \>64                  \<0.03 to \>64        75                
  Ceftazidime                                                      \>64                  2 to \>64             45                
  Ceftazidime-avibactam                                            32                    0.06 to \>64          NA                
  Colistin                                                         2                     1 to 2                100               
  Aztreonam                                                        32                    8 to 32               NA                
  Amikacin                                                         16                    \<4 to \>64           95                
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         70                
  Cefepime                                                         \>16                  \<0.5 to \>16         70                
  Tigecycline                                                      2                     \<0.25 to 4           NA                
  P. aeruginosa, MDR (*n* = 32)                                    Cefiderocol           1                     \<0.03 to \> 64   97
  Ceftolozane-tazobactam                                           \>64                  0.5 to \>64           66                
  Meropenem                                                        \>64                  0.5 to \>64           16                
  Ceftazidime                                                      \>64                  1 to \>64             34                
  Ceftazidime-avibactam                                            \>64                  1 to \>64             66                
  Colistin                                                         8                     1 to \> 8             75                
  Aztreonam                                                        32                    2 to \>32             9                 
  Amikacin                                                         64                    \<4 to \>64           69                
  Ciprofloxacin                                                    \>4                   \<0.25 to \>4         9                 
  Cefepime                                                         \>16                  2 to \>16             16                
  Tigecycline                                                      \>4                   1 to \>4              NA                
  S. maltophilia (*n* = 50)                                        Cefiderocol           0.25                  \<0.03 to 4       100
  Ceftolozane-tazobactam                                           \>64                  0.5 to \>64           NA                
  Meropenem                                                        \>64                  1 to \>64             NA                
  Ceftazidime                                                      \>64                  2 to \>64             38                
  Ceftazidime-avibactam                                            \>64                  1 to \>64             NA                
  Colistin                                                         \>8                   \<0.5 to \>8          NA                
  Trimethoprim-sulfamethoxazole                                    0.5/9.5               \<0.03/0.57 to 2/38   98                
  Amikacin                                                         \>64                  \<4 to \>64           NA                
  Ciprofloxacin                                                    \>4                   0.5 to \>4            NA                
  Cefepime                                                         \>16                  8 to \>16             NA                
  Tigecycline                                                      \>4                   \<0.25 to \>4         NA                
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Overall, 466 (97.5%) of the 478 isolates were susceptible to CFDC. Selected susceptibility test results are shown in [Table 1](#T1){ref-type="table"}. Against 52 extended-spectrum β-lactamase (ESBL)-positive E. coli isolates, CFDC had an MIC~90~ value of 2.0 mg/liter (range, \<0.03 to 4.0 mg/liter). Comparator agents active against these isolates included amikacin, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, and tigecycline. Against 37 ESBL-positive K. pneumoniae isolates, CFDC had an MIC~90~ value of 2.0 mg/liter. Overall, 36 (97%) of 37 isolates were susceptible to CFDC, with a lone isolate having an MIC of \>64.0 mg/liter. Among comparator agents, amikacin, ceftazidime-avibactam, and meropenem had appreciable activity against these isolates.

 {#s2}

Activity against carbapenem-resistant *Enterobacteriaceae*. {#s2.1}
-----------------------------------------------------------

Forty carbapenem-resistant *Enterobacteriaceae* (CRE) (23 K. pneumoniae, 10 E. coli, and 7 Enterobacter cloacae) were tested. The MIC~90~ of CFDC against these isolates was 4.0 mg/liter, with 37 (92.5%) of the 40 isolates having CFDC MICs of ≤4.0 mg/liter. Three isolates (7.5%) had CFDC MICs of \>4 mg/liter, including 2 *Klebsiella* and one *Enterobacter* species isolates. Among comparator agents, only tigecycline was active against these organisms, with an MIC~90~ of 4.0 mg/liter.

Activity against other *Enterobacteriaceae*. {#s2.2}
--------------------------------------------

Cefiderocol had good activity against ESBL-negative E. coli and *Klebsiella* spp. and against *Citrobacter* spp. and *Serratia* spp. (data not shown). Among comparator agents, amikacin, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, and tigecycline were active against these isolates. Most agents were less active against E. cloacae than they were against *Citrobacter* spp. While CFDC inhibited 34 (89%) of 38 *Enterobacter* species isolates at ≤4.0 mg/liter, 2 isolates had MICs of 8.0 mg/liter and 2 had MICs of \>64.0 mg/liter. All agents except colistin had good activity against *Serratia* spp.

Activity against nonfermenting Gram-negative bacilli. {#s2.3}
-----------------------------------------------------

CFDC was the most active agent tested against S. maltophilia isolates, with an MIC~90~ of 0.25 mg/liter and a range of \<0.03 to 4.0 mg/liter. Among comparators, only trimethoprim-sulfamethoxazole was active against S. maltophilia isolates, CFDC was active against Acinetobacter spp. isolates (MIC~90~, 4.0 mg/liter). Two of 20 isolates tested were resistant to CFDC, with MICs of 16.0 and \>64.0 mg/liter, respectively. Among comparator agents, amikacin, colistin, and tigecycline inhibited ≥90% of isolates. The MIC~90~ of CFDC against 15 isolates of *Achromobacter* spp. was 0.125 mg/liter. Among comparator agents, imipenem had the best activity.

CFDC inhibited all 38 P. aeruginosa isolates that did not exhibit multidrug resistance (MDR) at ≤1.0 mg/liter. Comparator agents with activity against these isolates included ceftolozane-tazobactam, ceftazidime-avibactam, amikacin, colistin, and ceftazidime. Against 32 MDR P. aeruginosa isolates, CFDC was the most active agent tested, with an MIC~90~ of 1.0 mg/liter. Only 1 isolate was resistant to CFDC, with an MIC of \>64.0 mg/liter. The activity of comparator agents against these isolates was uniformly poor.

Activity against uncommon organisms. {#s2.4}
------------------------------------

Cefiderocol inhibited all 7 Burkholderia cepacia isolates at ≤0.25 mg/liter, all 7 *Pantoea* spp. isolates at ≤1.0 mg/liter, all 7 Sphingomonas paucimobilis isolates at ≤0.5 mg/liter, and all 3 Elizabethkingia meningoseptica isolates at ≤4.0 mg/liter. One of 8 Rhizobium radiobacter isolates was nonsusceptible to CFDC (MIC, 8.0 mg/liter).

Nonsusceptible isolates. {#s2.5}
------------------------

CFDC was associated with the lowest level of nonsusceptibility ([Table 1](#T1){ref-type="table"}). The highest level of nonsusceptibility to CFDC was seen among non-CRE *Enterobacter* spp. isolates, with 2 (5.3%) of 38 isolates being nonsusceptible. Many comparators had nonsusceptibility percentages of \<2%. Of note, MDR P. aeruginosa nonsusceptibility to CFDC was 3.1%, whereas the nonsusceptible range for comparator agents was 25% to 91%. The MIC distributions for individual organisms and antimicrobial agents are presented in [Table 2](#T2){ref-type="table"}. Distributions for CFDC showed lower MICs for nonsusceptible organisms, including CRE, MDR P. aeruginosa, and S. maltophilia, than those of all other agents tested.

###### 

*In vitro* activity of cefiderocol and comparator agents against commonly resistant bacterial isolates from cancer patients using MIC distribution data

  Isolate, type                   Antimicrobial agent      Distribution (*n*) at MIC (mg/liter) of:                                                                 
  ------------------------------- ------------------------ ------------------------------------------ --- ---- ---- ---- ---- ---- ---- --- ---- ---- ---- --- ---- -----------------------
  ESBL positive                                                                                                                                                     
   E. coli (*n* = 52)             Cefiderocol              2                                              2    7    3    14   13   8    3                           
                                  Meropenem                32                                         2   14   3    1                                               
                                  Ceftolozane-tazobactam                                                       6    15   14   3    3    3   1    1    1    3   2    
                                  Ceftazidime                                                                                 3    1    4   7    12   7    8   10   
                                  Ceftazidime-avibactam    3                                              5    18   15   3    4    2    2                           
                                  Cefepime                                                                                    2    2    4   8    11                 
                                  Aztreonam                                                                                   1         3   11   10   19            
                                  Amikacin                                                                                                  14   7    1             
                                  Colistin                                                                                    48   3    1                           
                                  Ciprofloxacin                                                                     2              1                                2 (\<0.25); 47 (\>4)
   K. pneumoniae (*n* = 37)       Cefiderocol                                                                  8    16   8         4                           1    
                                  Meropenem                5                                              14   14   1    1              1                           
                                  Ceftolozane-tazobactam                                                            2    7    4    10   8   1         2        3    
                                  Ceftazidime                                                                                           1   1    3    8    8   16   
                                  Ceftazidime-avibactam    1                                              1    3    15   13   3                                1    
                                  Cefepime                                                                                    1    3        4    5                  24 (\>16)
                                  Aztreonam                                                                                                 1    6    22            8 (\>32)
                                  Amikacin                                                                                                  6    4             2    25 (\<4)
                                  Colistin                                                                                    23   8    1                           5 (\>8)
                                  Ciprofloxacin                                                                               1    5    2                           4 (\<0.25); 25 (\>4)
                                  Tigecycline                                                                            4    3    6    7                           10 (\<0.25); 7 (\>4)
  E. cloacae (*n* = 38)           Cefiderocol              1                                              1    1    3    9    8    8    3   2                  2    
                                  Meropenem                10                                             8    6    6    4    0    1    1   1              1        
                                  Ceftolozane-tazobactam                                                  1    6    7    3    1    3    1   5    2    2    1   6    
                                  Ceftazidime                                                                       9    4    1             1    3    3        19   
                                  Ceftazidime-avibactam                                                        4    12   6    8    3    3        16                 
                                  Cefepime                                                                                    1    2    2   1    2                  22 (\<0.5); 8 (\>!6)
                                  Aztreonam                                                                                   3    1    3        2    9             10 (\<0.5); 10 (\>32)
                                  Amikacin                                                                                                  3    3                  32 (\<4)
                                  Colistin                                                                                    18   4    1   1                       14 (\>8)
                                  Ciprofloxacin                                                                               2    4                                24 (\<0.5); 8 (\>4)
                                  Tigecycline                                                                            6    4    3    2                           21 (\<0.5); 2 (\>4)
  CRE                                                                                                                                                               
      E. coli (*n* = 10)          Cefiderocol                                                             2         2         3    2        1                       
                                  Meropenem                                                                                        1    2   4    1         1   1    
                                  Ceftolozane-tazobactam                                                                           1    1   1    1    1    1   4    
                                  Ceftazidime                                                                                                    2         2   6    
                                  Ceftazidime-avibactam                                                             1    1    3    1        2                  2    
                                  Cefepime                                                                                                  1                       9 (\>16)
                                  Aztreonam                                                                                                      2    8             
                                  Amikacin                                                                                                       2    1    1   2    4 (\<4)
                                  Colistin                                                                                    7    1                                2 (\<0.5)
                                  Ciprofloxacin                                                                                                                     10 (\>4)
                                  Tigecycline                                                                            1    2    1    2                           4 (\<0.25)
      K. pneumoniae (*n* = 23)    Cefiderocol                                                             1         3    4    5    5    4                      1    
                                  Meropenem                2                                                             1              2   3         5    2   8    
                                  Ceftolozane-tazobactam                                                                 2    1    1                  6    3   10   
                                  Ceftazidime                                                                                                         1    2   19   
                                  Ceftazidime-avibactam                                                   1    2    3    5    2    2    2   1    1             4    
                                  Cefepime                                                                                                                          23 (\>16)
                                  Aztreonam                                                                                                      1    8             13 (\>32)
                                  Amikacin                                                                                                  6    1    4    1   2    9 (\<4)
                                  Colistin                                                                                    16   1        2                       4 (\>8)
                                  Ciprofloxacin                                                                                    1                                22 (\>4)
                                  Tigecycline                                                                            1    5    5    8                           3 (\<0.25); 1 (\>4)
      E. cloacae (*n* = 7)        Cefiderocol                                                                  1    1         2    1    2                           
                                  Meropenem                                                               2    1    1              1                       2        
                                  Ceftolozane-tazobactam                                                                      1    2    2                      2    
                                  Ceftazidime                                                                                                    1    2        4    
                                  Ceftazidime-avibactam                                                             1    4                                     2    
                                  Cefepime                                                                                    1         1        1             1    3 (\<0.5)
                                  Aztreonam                                                                                                      2    2             3 (\>32)
                                  Amikacin                                                                                                                          6 (\<4)
                                  Colistin                                                                                    3    1                                3 (\>8)
                                  Ciprofloxacin                                                                                                                     6 (\<0.25); 1 (\>4)
                                  Tigecycline                                                                                 1    3    1                           2 (\<0.25)
  P. aeruginosa, MDR (*n* = 32)   Cefiderocol              6                                              9    6    6         4                                1    
                                  Meropenem                                                                              1    1    3        9    9    5        4    
                                  Ceftolozane-tazobactam                                                                 5    7    7    2   2    2             7    
                                  Ceftazidime                                                                                 2         6        2    6    8   8    
                                  Ceftazidime-avibactam                                                                       5    2    9   5    3    4        4    
                                  Cefepime                                                                                         2    2   1    15                 12 (\>16)
                                  Aztreonam                                                                                        1    2        14   13            2 (\>32)
                                  Amikacin                                                                                                  7    3    2    6   2    12 (\<4)
                                  Colistin                                                                                    3    21   4   2                       2 (\>8)
                                  Ciprofloxacin                                                                          1    2    6    3                           3 (\<0.25); 17 (\>4)
                                  Tigecycline                                                                                 1    1                                30 (\>4)
  Acinetobacter spp. (*n* = 20)   Cefiderocol              8                                              4    1    2    1    1         1        1             1    
                                  Meropenem                1                                              1    2    8    3                  1         1        3    
                                  Ceftolozane-tazobactam   8                                              1    2         1    1    3             1             3    
                                  Ceftazidime                                                                                      4    3   2    3    3    2   3    
                                  Ceftazidime-avibactam                                                   1    1         1    2    3    4   3    2    1        2    
                                  Cefepime                                                                                    7    3    1   2    1                  2 (\<0.5); 4 (\>16)
                                  Aztreonam                                                                                                 1    10   9             
                                  Amikacin                                                                                                  1    2             1    16 (\<4)
                                  Colistin                                                                                    9    11                               
                                  Ciprofloxacin                                                                          1                                          13 (\<0.5); 6 (\>4)
                                  Tigecycline                                                                            1    4    5    1                           9 (\<0.25)
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Illumina MiSeq short-read whole-genome sequencing was performed for the CFDC-resistant isolates, followed by an analysis focused on the presence of β-lactamase-encoding genes and the composition of major porins known to contribute to β-lactam resistance. ([@B9]) *Klebsiella* spp. isolates demonstrated outer membrane porin OmpK36, OmpK37, and OmpK35 disruption and the presence of various β-lactamases. The *Enterobacter* spp. isolates had alterations in OmpC and OmpF and the presence of AmpC and ESBLs. Finally, Acinetobacter spp. isolates had carbapenemases and various β-lactamases. No clear mechanisms for CFDC resistance were found.

The standard of care for the treatment of febrile episodes in cancer patients is prompt administration of empirical antibiotic therapy ([@B10]). GNOs are now the predominant bacterial pathogens in this setting, and resistance among many GNOs is increasing. CFDC has potent *in vitro* activity against various GNOs isolated from patients with cancer, including carbapenem-resistant organisms and MDR nonlactose fermenting organisms, including S. maltophilia. Based on these *in vitro* findings and the general exclusion of patients with cancer from registration studies, we believe future study of the clinical utility of CFDC in patients with cancer is warranted.
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